This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.
Tesamorelin
Growth Hormone-Releasing Peptide
/WHAT_IT_IS
Tesamorelin is a synthetic analog of GHRH that promotes the natural release of growth hormone and has shown clinical effectiveness in reducing visceral fat.
/USAGE
Commonly used in research focused on lipodystrophy, particularly in HIV patients, and explored for cognitive and metabolic benefits.
/MECHANISM_OF_ACTION
Stimulates the pituitary gland to secrete growth hormone by binding to GHRH receptors.
Reported Benefits
- +Reduces visceral adipose tissue
- +Enhances GH secretion
- +May improve lipid profiles
- +Supports cognitive function
Reported Side Effects
- −Injection site redness
- −Water retention
- −Tingling or numbness in extremities
/STACKED_WITH
/RESEARCH_NOTES
Clinically approved for HIV-associated lipodystrophy. Being studied for general metabolic optimization.
/REFERENCE
https://pubmed.ncbi.nlm.nih.gov/22869065//RELATED
Browse all 89 in the app.
MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.